Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice

LCZ696 (sacubitril/valsartan) is an angiotensin receptor-neprilysin inhibitor and has shown beneficial effects in patients with heart failure. However, whether LCZ696 protects against left atrial (LA) and LA appendage (LAA) dysfunction is still unclear. The present study aimed to assess the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Suo, Ya, Yuan, Meng, Li, Hongmin, Zhang, Yue, Li, Ying, Fu, Huaying, Han, Fei, Ma, Changhui, Wang, Yuanyuan, Bao, Qiankun, Li, Guangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830387/
https://www.ncbi.nlm.nih.gov/pubmed/31736759
http://dx.doi.org/10.3389/fphar.2019.01285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830387/
https://www.ncbi.nlm.nih.gov/pubmed/31736759
http://dx.doi.org/10.3389/fphar.2019.01285

Ejemplares similares